タンパク質特性解析市場- 世界の産業規模、シェア、動向、機会、予測、製品・サービス別、用途別、最終用途別、地域別、競合別、2020-2030年

タンパク質特性解析の世界市場規模は2024年に154億5,000万米ドル、2030年には340億7,000万米ドルに達すると予測、CAGRは14.06%。

世界のタンパク質特性解析市場は、プロテオミクスが重視されるようになり、細胞機能や疾病メカニズムの解明においてその役割が高まっているため、堅調な拡大が見られます。重要なバイオマーカーや治療標的であるタンパク質は、創薬、診断、個別化医療の中心です。このため、バイオテクノロジー企業や製薬企業は、高度なタンパク質分析技術への投資を促しています。質量分析、クロマトグラフィー、電気泳動などのツールは、タンパク質の構造、翻訳後修飾、相互作用の研究に広く使用されています。精密医療や生物製剤に対する需要の高まりは、正確なタンパク質プロファイリングの必要性をさらに加速させています。ライフサイエンス研究に対する政府助成金の増加や、学術機関と企業間の共同研究の活発化が、市場の拡大を支えています。

市場を形成する動向には、タンパク質解析における人工知能と機械学習の統合が含まれ、より迅速なデータ処理と予測モデリングを可能にしています。自動化とハイスループットスクリーニング技術により、解析時間の短縮と再現性の向上が図られ、大規模アプリケーションの効率が向上しています。プロテオミクスとゲノミクスおよびメタボロミクスを組み合わせたマルチオミクスアプローチの出現は、生物学的洞察の深さを高め、包括的なプロファイリングを促しています。小型化されたラボオンチップ・プラットフォームは、特に臨床診断におけるポイントオブケア・アプリケーションの牽引役となっています。業界各社は、シームレスなデータ統合、解釈、可視化を可能にする使いやすいソフトウェアツールの開発にも注力しており、研究者の発見を加速させています。

主要市場促進要因

生物製剤とバイオシミラーの需要増加

主な市場課題

機器と分析サービスの高コスト

主な市場動向

モノクローナル抗体と生物製剤開発の増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のタンパク質特性解析市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品・サービス別（消耗品、機器、サービス）
  • 用途別（創薬・開発、臨床診断、その他）
  • 用途別（製薬・バイオテクノロジー企業、学術調査機関、受託調査機関、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米のタンパク質特性解析市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のタンパク質特性解析市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のタンパク質特性解析市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のタンパク質特性解析市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのタンパク質特性解析市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Eurofins Scientific
• Merck KGAA
• Promega Corporation
• Qiagen N.V.
• Sartorius AG

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Protein Characterization Market was valued at USD 15.45 Billion in 2024 and is expected to reach USD 34.07 Billion by 2030 with a CAGR of 14.06%. The Global Protein Characterization Market is witnessing robust expansion due to the growing emphasis on proteomics and its role in understanding cellular functions and disease mechanisms. Proteins, being key biomarkers and therapeutic targets, are central to drug discovery, diagnostics, and personalized medicine. This has prompted biotechnology and pharmaceutical companies to invest in advanced protein analysis technologies. Tools such as mass spectrometry, chromatography, and electrophoresis are widely used to study protein structure, post-translational modifications, and interactions. Increasing demand for precision medicine and biologics has further accelerated the need for accurate protein profiling. Rising government funding for life sciences research and an uptick in collaborations between academic institutions and industry players are supporting the market's expansion.

Trends shaping the market include the integration of artificial intelligence and machine learning in protein analysis, enabling faster data processing and predictive modeling. Automation and high-throughput screening technologies are reducing analysis time and improving reproducibility, making protein characterization more efficient for large-scale applications. The emergence of multi-omics approaches, combining proteomics with genomics and metabolomics, is enhancing the depth of biological insights and encouraging comprehensive profiling. Miniaturized and lab-on-chip platforms are gaining traction for point-of-care applications, especially in clinical diagnostics. Industry players are also focusing on developing user-friendly software tools that allow seamless data integration, interpretation, and visualization, helping researchers accelerate discoveries.

Key Market Drivers

Rising Demand for Biologics and Biosimilars

The increasing demand for biologics and biosimilars is a significant driver for the Global Protein Characterization Market. Biologics, including monoclonal antibodies, therapeutic proteins, and vaccines, are revolutionizing the treatment of various diseases, particularly in oncology, autoimmune disorders, and genetic diseases. As these therapies continue to grow in importance, the need for precise and comprehensive protein characterization and identification becomes crucial. Protein characterization techniques allow for the analysis of protein structures, functions, and interactions, which is vital for ensuring the safety, efficacy, and quality of biologic drugs.

In 2023, the U.S. Food and Drug Administration (FDA) approved 55 new drugs, of which 17 were biologics, accounting for 30.9% of all drug approvals. Notably, 12 of these biologics were monoclonal antibodies, marking a significant milestone in biologic drug development. The Center for Biologics Evaluation and Research (CBER) added 23 new biologics license application approvals in 2023, highlighting the growing focus on biologic therapies.

Similarly, the European Medicines Agency (EMA) recommended 77 medicines for marketing authorization in 2023, with 39 having a new active substance. This indicates a strong emphasis on innovative therapies, including biologics, in the European market.

The increasing focus on biosimilars, which are similar to original biologic drugs but at a lower cost, further fuels the demand for protein characterization. As the patents of several blockbuster biologics expire, pharmaceutical companies are investing heavily in the development of biosimilars to tap into this growing market. Ensuring the structural and functional similarity of biosimilars to their reference biologics is critical, and this requires advanced protein characterization methods such as mass spectrometry, chromatography, and peptide mapping.

Regulatory agencies worldwide, including the FDA and EMA, have established rigorous guidelines to assess the quality and safety of biologics and biosimilars, which in turn drives the need for precise protein identification techniques. As biologic therapies gain popularity and the biosimilars market expands, the demand for protein characterization and identification solutions will continue to rise, accelerating market growth and innovation in this sector.

Key Market Challenges

High Cost of Instruments and Analytical Services

The high cost of instruments and analytical services remains a significant challenge for the Global Protein Characterization Market. Cutting-edge protein characterization tools such as mass spectrometers, chromatography systems, and protein analyzers are critical for accurate and reliable results. These advanced instruments often come with hefty price tags, making them unaffordable for smaller research institutions, universities, and laboratories, particularly in emerging markets. The expense associated with these technologies can create a barrier to entry for organizations with limited financial resources, thereby hindering widespread adoption of advanced protein characterization methods.

Beyond the high initial purchase cost, maintaining and operating these instruments requires specialized training, skilled personnel, and regular servicing, all of which add to the ongoing expenses. The need for highly trained technicians and scientists to operate these advanced technologies further drives up operational costs. Additionally, the reliance on specialized reagents and consumables for protein analysis can contribute to the overall expense. For many research entities, these financial constraints may limit the frequency of protein characterization studies and the scope of their research projects.

Key Market Trends

Rise in Monoclonal Antibody and Biologics Development

The rise in monoclonal antibody (mAb) and biologics development is significantly driving the Global Protein Characterization Market. With the growing emphasis on biologic therapies, including monoclonal antibodies, protein characterization and identification have become essential to ensuring the safety, efficacy, and consistency of these therapies. As biologics are increasingly utilized for treating chronic diseases, cancers, and autoimmune conditions, accurate protein analysis is vital to understanding their molecular structures, functionality, and therapeutic potential. This trend is particularly pronounced with the growing use of mAbs, which are highly complex molecules that require precise characterization for both drug development and regulatory approval.

The growing complexity of biologics has led to increased demand for advanced proteomics tools, such as mass spectrometry and chromatography, to analyze proteins and their interactions. This demand is expected to rise as the pharmaceutical industry focuses on personalized medicine, where the detailed profiling of proteins in the context of individual patients is crucial. Accurate protein identification is pivotal in the development of next-generation biologics, as even slight structural variations can impact the therapeutic outcome.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Eurofins Scientific
• Merck KGAA
• Promega Corporation
• Qiagen N.V.
• Sartorius AG

Report Scope:

In this report, the Global Protein Characterization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Characterization Market, By Product & Services:

• Consumables
• Instruments
• Services

Protein Characterization Market, By Application:

• Drug Discovery & Development
• Clinical Diagnosis
• Others

Protein Characterization Market, By End-Use:

• Pharmaceuticals & Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

Protein Characterization Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Characterization Market.

Available Customizations:

Global Protein Characterization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Protein Characterization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Consumables, Instruments, Services)
  • 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Protein Characterization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services
  • 6.2.2. By Application
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Characterization Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Mexico Protein Characterization Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Canada Protein Characterization Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Use

7. Europe Protein Characterization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services
  • 7.2.2. By Application
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Protein Characterization Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Use
  • 7.3.2. Germany Protein Characterization Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Protein Characterization Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Protein Characterization Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Protein Characterization Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Use

8. Asia-Pacific Protein Characterization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services
  • 8.2.2. By Application
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Protein Characterization Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Protein Characterization Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Use
  • 8.3.3. South Korea Protein Characterization Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Use
  • 8.3.4. Japan Protein Characterization Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Protein Characterization Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Use

9. South America Protein Characterization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services
  • 9.2.2. By Application
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Protein Characterization Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Use
  • 9.3.2. Argentina Protein Characterization Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Use
  • 9.3.3. Colombia Protein Characterization Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Use

10. Middle East and Africa Protein Characterization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services
  • 10.2.2. By Application
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Protein Characterization Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Saudi Arabia Protein Characterization Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Use
  • 10.3.3. UAE Protein Characterization Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Agilent Technologies, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Bio-Rad Laboratories, Inc.
• 14.3. Bruker Corporation
• 14.4. Thermo Fisher Scientific Inc.
• 14.5. Danaher Corporation
• 14.6. Eurofins Scientific
• 14.7. Merck KGAA
• 14.8. Promega Corporation
• 14.9. Qiagen N.V.
• 14.10. Sartorius AG

15. Strategic Recommendations

16. About Us & Disclaimer